No Data
No Data
Libertech: 2024 Annual Results Forecast Announcement
2024 Annual Results Forecast Announcement
Beijing LabTech Instruments (688056.SH): Net income for 2024 is expected to increase by 45.12% to 56.01%.
On January 22, Glint Securities reported that Beijing LabTech Instruments (688056.SH) announced its performance forecast for 2024, expecting a net income attributable to the parent company owners to be between 40 million yuan and 43 million yuan, an increase of 45.12% to 56.01% year-on-year. The net income attributable to the parent company owners, excluding non-recurring gains and losses, is expected to be between 31.82 million yuan and 34.82 million yuan, an increase of 36.56% to 49.43% year-on-year.
Beijing LabTech Instruments (688056.SH): The company's downstream customers are spread across various industries such as Semiconductors and New energy Fund.
Gelonghui, January 7th丨Beijing LabTech Instruments (688056.SH) recently stated during an institutional investor survey that the company's downstream clients are spread across various sectors such as Eco-friendly Concept, food, Medical, pharmaceuticals, geology, nuclear industry, Semiconductors, petrochemicals, and New energy Fund. The types of clients mainly include government departments, research Institutions, higher education institutions, and comprehensive testing manufacturers.
Beijing LabTech Instruments (688056.SH): Re-identified as a high-tech enterprise.
On December 17, Gelonghui reported that Beijing LabTech Instruments (688056.SH) announced that it recently received the "High-tech Enterprise Certificate" jointly issued by the Peking Science and Technology Commission, Peking Finance Bureau, and the State Taxation Administration Peking Taxation Bureau. The certificate number is: GR202411001099, the issuance date is October 29, 2024, and the validity period is three years. This recognition is a re-evaluation after the expiration of the previous high-tech enterprise certificate.
gtja: The government is offering price discounts on domestic products for procurement, which is bullish for domestic scientific instruments.
Currently, as long as the product is produced in our country, it is considered a domestic product in government procurement activities.